Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis
Clinical trial NCT06827587 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06827587
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.